Takuva S

ORCID: 0000-0001-6030-2359 · 1 paper in corpus
2022
Allergic reactions to the Ad26.COV2.S vaccine in South Africa.
The journal of allergy and clinical immunology. Global ·doi:10.1016/j.jacig.2021.12.002

BackgroundThe Janssen-Ad26.COV2.S vaccine is authorized for use in several countries, with more than 30 million doses administered. Mild and severe allergic adverse events following immunization (AEFI) have been reported.ObjectiveWe sought …